![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||
A rational scale for assessing the harm of drugs of misuseFor immediate release See embargoed press release from The Lancet below. Danny Kushlick, Director of Transform Drug Policy Foundation said:
Danny Kushlick Director Lancet Press ReleaseEMBARGO: 00:01H (UK time) Friday March 23, 2007 The current UK classification of psychoactive drugs into three categories (A, B, or C), has poor correlation with expert ratings of the specific harms* caused by different drugs, and should be changed, according to a Health Policy article published in this week's issue of The Lancet. Illicit drugs are regulated according to classification systems that claim to relate to the harms and risks of each drug. However, the methodology and processes underlying classification are neither specified nor transparent, and this has led to a lack of confidence in their accuracy and undermines health education messages. The UK drug classification has evolved over nearly a century in an unsystematic way by small changing groups of experts. The information available to them has varied in quantity and quality, and has led to drugs receiving the most risky classification with little scientific basis, with limited opportunity to revise these rankings. David Nutt (University of Bristol, UK) and colleagues consulted a wide variety of experts to assess the harms of various illicit drugs? using an evidence-based approach, revising their ratings accordingly, and using statistical methods to derive overall rankings of risk. Although the two substances with the highest harm ratings (heroin and cocaine) were class A, overall the independent expert group found that the correlation between classification by the Misuse of Drugs Act and harm rating was not significant. Of both the eight substances that scored highest and the eight that scored lowest, three were class A and two were unclassified. Alcohol, ketamine, tobacco, and solvents (all unclassified at the time of assessment) were ranked more harmful than LSD, ecstasy, and its variant 4-MTA (all class A drugs). The authors conclude: "The results of this study do not provide justification for the sharp A, B, or C divisions of the current classifications of the Misuse of Drugs Act. . .We believe a system of classifications like ours, based on the scoring of harms by experts, on the basis of scientific evidence, has much to commend it...The system is rigorous and transparent, and involves formal quantitative assessment of several aspects of harm [and] it can be easily reapplied as knowledge advances". pressoffice@lancet.com
--------- Transform Drug Policy Foundation is a registered charity no 1100518
|
||
|
||
|